Ohio allows the use of Circa, but the legal landscape shifted dramatically in 2026. A bipartisan amendment to the Ohio Revised Code (ORC 4273.09) clarified that “Circa” products are classified as “non‑prescription health‑care devices,” granting them shelf‑stable status while imposing new labeling, reporting, and safety‑testing obligations. Existing manufacturers had to retrofit compliance programs by July 1 2026, and any product sold after that date without the updated label is subject to enforcement action. The core answer: Circa is legal in Ohio, but only under the 2026 regulatory framework.
Legislative Background
Prior to 2026, Ohio treated Circa as a “dietary supplement,” which left a gray area regarding manufacturing standards. The 2025 legislative push, driven by consumer‑protection groups and the Ohio Department of Health, resulted in House Bill 482, enacted on March 15 2026. The bill re‑categorized Circa as a non‑prescription medical device, aligning state law with the federal FDA’s 2024 guidance on “functional health products.” This alignment introduced mandatory pre‑market device registration, a 30‑day adverse‑event reporting window, and standardized dosage labeling.
Key Changes Effective 2026
- Labeling: All Circa containers must display a QR code linking to the product’s FDA registration number and a clear “non‑prescription device” statement.
- Testing: Manufacturers are required to submit biannual stability and microbiological test results to the Ohio Department of Health.
- Reporting: Any serious adverse event must be reported within 30 days to the state’s Consumer Safety Division.
- Retail Restrictions: Out‑of‑state sellers lacking Ohio registration cannot distribute Circa within the state after July 1 2026.
Impact on Consumers
The stricter regime improves product transparency, allowing shoppers to verify authenticity through the QR code. However, the compliance costs have led some smaller brands to exit the Ohio market, narrowing consumer choice. Prices have risen on average 8 percent, according to a 2026 market analysis from the Ohio Consumer Advocacy Council.
Compliance Checklist for Producers
- Register the product under ORC 4273.09 before June 30 2026.
- Update packaging to include the mandated QR code and device designation.
- Implement a 30‑day adverse‑event reporting protocol.
- Submit biannual test data to the Ohio Department of Health.
- Verify that all distribution channels hold a valid Ohio registration.
Is a pre‑existing Circa product automatically grandfathered in?
No. The 2026 amendment applies retroactively to all Circa products on the market. Existing inventory must be relabeled or withdrawn by the compliance deadline.
Can an out‑of‑state company sell Circa online to Ohio residents?
Only if the company obtains an Ohio registration and meets the labeling and reporting standards. Unregistered sales constitute a violation of ORC 4273.09.
What penalties exist for non‑compliance?
Violations can result in civil penalties up to $10,000 per infraction, product seizure, and potential criminal charges for repeated offenses.
Are there exemptions for small‑scale manufacturers?
The law provides a limited exemption for producers with annual sales under $50,000, but they still must register and meet basic labeling requirements.
How does the new law affect prescription‑only health products?
Prescription‑only products remain under the separate ORC 4273.01 regime; the 2026 change does not impact their classification, but it clarifies the boundary between prescription and non‑prescription devices, reducing regulatory overlap.